ArticleTherapeutic advances in drug safety2025

Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib.

Alessio Provenzani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.